drugset / Trial / NCT03585569
" Treating MS Patients With Lower Extremity Spasticity Using Dysport"
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Dysport® (abobotulinumtoxinA) injections for lower extremity spasticity showed a significant reduction of lower extremity spasticity after being injected with Dysport® (abobotulinumtoxinA) in patients with MS.
Timeline
- Start
- 2018-05-01
- Primary completion
- 2019-05
- Completion
- 2020-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |